China’s Simcere in licensing deal with German firm on Alzheimer’s disease targeted agents 29-Jun-2021 By Jane Byrne Simcere has announced a partnership with Vivoryon whereby it will leverage the potential of innovative N3pE amyloid-targeting agents to treat Alzheimer’s disease (AD) in Greater China.